Poor Sleep Quality May Independently Predict Suicidal Risk in Covid-19 Survivors: A 2-Year Longitudinal Study.

anxiety depression poor sleep post-COVID survivors suicidal ideation

Journal

Clinical neuropsychiatry
ISSN: 2385-0787
Titre abrégé: Clin Neuropsychiatry
Pays: Italy
ID NLM: 101237961

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 4 10 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: ppublish

Résumé

Multiple symptoms of psychiatric, neurological, and physical illnesses may be part of Post-COVID conditions and may pose COVID-19 survivors a high suicidal risk. Accordingly, we aimed to study factors contributing to suicidal risk in Post COVID-19 patients. Consecutive patients with post COVID-19 conditions were followed for 2 years at the University Hospital of Ferrara at baseline (T0), 6 (T1), 12 (T2), and 24 (T3) months. Demographics, and clinical data for all patients included: disease severity, hospital length of stay, comorbidity, clinical complications, sleep quality, cognitive complaints, anxiety and stress-related symptoms, depressive symptoms, and suicidal ideation. The final sample included 81 patients with post COVID survivors. The mean age was 64 + 10,6 years, 35,8% were females, 65,4% had medical comorbidities, and 69,1% had WHO severe form of COVID forms. At T0 more than 90% of patients showed poor sleep quality, 59.3% reported moderate/severe depressive symptoms, and 51.% experienced anxiety, 25.9% experienced post-traumatic stress symptoms. At T0 suicidal ideation, interested 6.1% and at T3 it increased to 7.4%. In the regression analysis, suicidal ideation at baseline was best predicted by poor sleep quality (O.R. 1.71, p=0.044) and, after 2 years, suicidal ideation was best predicted by poor sleep quality experienced at baseline (OR 67.3, p=0.001). Poor sleep quality may play as an independent predictor of suicidal risk in post-COVID survivors. Evaluating and targeting sleep disturbances in COVID survivors is important to prevent the consequences of disrupted sleep in mental health.

Identifiants

pubmed: 37791092
doi: 10.36131/cnfioritieditore20230406
pmc: PMC10544237
doi:

Types de publication

Journal Article

Langues

eng

Pagination

271-278

Informations de copyright

© 2023 Giovanni Fioriti Editore s.r.l.

Déclaration de conflit d'intérêts

Competing interests: None.

Références

J Neurol Sci. 2022 Mar 15;434:120162
pubmed: 35121209
QJM. 2020 Oct 1;113(10):707-712
pubmed: 32539153
Brain Nerve. 2022 Jul;74(7):879-884
pubmed: 35860935
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Curr Psychiatry Rep. 2013 Sep;15(9):389
pubmed: 23949486
J Pers Med. 2022 Dec 07;12(12):
pubmed: 36556240
J Consult Clin Psychol. 1979 Apr;47(2):343-52
pubmed: 469082
J Sleep Res. 2023 Aug;32(4):e13842
pubmed: 36748346
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Nat Rev Immunol. 2019 Nov;19(11):702-715
pubmed: 31289370
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Mayo Clin Proc. 2021 Jul;96(7):1782-1791
pubmed: 34218857
J Sleep Res. 2022 Aug;31(4):e13604
pubmed: 35460140
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
JMIR Form Res. 2022 Oct 25;6(10):e36656
pubmed: 35763757
Neurosci Biobehav Rev. 2020 Oct;117:65-77
pubmed: 31491473
Mol Psychiatry. 2021 Jun;26(6):2126-2136
pubmed: 32355334
Adv Exp Med Biol. 2023;1411:263-273
pubmed: 36949314
J Neurol Neurosurg Psychiatry. 2022 Aug 11;:
pubmed: 35953265
Sleep Med Rev. 2023 Apr;68:101760
pubmed: 36706699

Auteurs

Laura Palagini (L)

Department of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa, Via Roma 67, 56100 Pisa, Italy.

Gaspare Alfi (G)

Department of Surgical, Medical, Molecular, and Critical Area Pathology, University of Pisa, Via Savi, 10 - 56126 Pisa, Italy.

Diletta Dazzi (D)

Department of Neuroscience and Rehabilitation, Ferrara University, Ferrara, Italy.

Angelo Gemignani (A)

Department of Surgical, Medical, Molecular, and Critical Area Pathology, University of Pisa, Via Savi, 10 - 56126 Pisa, Italy.

Valerio Caruso (V)

Department of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa, Via Roma 67, 56100 Pisa, Italy.

Pierre A Geoffroy (PA)

Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France ; Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France; Université Paris Cité, NeuroDiderot, Inserm, Paris, France; CNRS UPR 3212, Institute for Cellular and Integrative Neurosciences, Strasbourg, France.

Mario Miniati (M)

Department of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa, Via Roma 67, 56100 Pisa, Italy.

Sofia Straudi (S)

Department of Neuroscience and Rehabilitation, Ferrara University, Ferrara, Italy.

Classifications MeSH